Shire for weSPARK
Today, Shire is the leading global biotechnology company focused on serving people with rare diseases. We trace our origins back to 1986, when a small team of entrepreneurs founded the company to seek out solutions to address a number of unmet medical needs. Within the first two years of operation, we launched a range of supplemental calcium products for patients seeking to treat or prevent osteoporosis. Soon after, the company had innovative drug development programs under way on behalf of patients facing challenging conditions such as Alzheimer's disease and end-stage renal failure.
Now, with medicines available in more than 100 countries, we are in a leading position to provide solutions globally that enable more patients and families around the world to live their lives to the fullest.